Aura Biosciences director granted RSUs, stock options
Aura Biosciences, Inc. director Jeremy Bender reported equity awards consisting of restricted stock units and stock options as part of his compensation.
Rhea-AI Filing Summary
Aura Biosciences, Inc. director Jeremy Bender reported equity awards consisting of restricted stock units and stock options as part of his compensation. He received 30,000 shares of Common Stock through an RSU award, with each unit representing one share. These RSUs vest in three substantially equal annual installments beginning on July 15, 2027, subject to his continued service.
He was also granted 60,000 stock options to purchase Common Stock at an exercise price of $7.03 per share, expiring on July 7, 2036. The option vests in three substantially equal annual installments beginning on July 7, 2027, conditioned on his continued service. After these awards, he holds 30,000 shares of Common Stock and 60,000 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 90,000 shares
Grant/Award
2 txns
Insider
Bender Jeremy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 60,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 60,000 contracts (Direct);
Common Stock — 30,000 shares (Direct)
Footnotes (2)
- F1. These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.
- F2. The shares underlying this option vest in three substantially equal annual installments beginning on July 7, 2027, subject to the Reporting Person's continued service as of each such vesting date.
Key Figures
RSU grant: 30,000 shares
Option grant: 60,000 options
Option exercise price: $7.03 per share
+5 more
8 metrics
RSU grant
30,000 shares
Restricted stock units representing Common Stock
Option grant
60,000 options
Stock Option (Right to Buy) underlying Common Stock
Option exercise price
$7.03 per share
Conversion or exercise price for stock options
RSU vesting start
July 15, 2027
First of three annual RSU vesting dates
Option vesting start
July 7, 2027
First of three annual option vesting dates
Option expiration
July 7, 2036
Expiration date of stock options
Shares after award
30,000 shares
Total Common Stock held following RSU acquisition
Options after award
60,000 options
Total stock options held following grant
Key Terms
restricted stock unit ("RSU"), 2021 Stock Option and Incentive Plan, Stock Option (Right to Buy), vest in three substantially equal annual installments, +1 more
5 terms
restricted stock unit ("RSU") financial
"These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan."
2021 Stock Option and Incentive Plan financial
"These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
vest in three substantially equal annual installments financial
"These RSUs vest in three substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service."
exercise price financial
"conversion_or_exercise_price": "7.0300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Jeremy Bender acquire in this Aura Biosciences (AURA) Form 4?
Jeremy Bender received equity compensation awards, not open-market trades. He acquired 30,000 restricted stock units and 60,000 stock options, both tied to Aura Biosciences’ Common Stock, subject to multi-year vesting and continued service conditions.
How many Aura Biosciences (AURA) RSUs were granted to Jeremy Bender?
He was granted 30,000 restricted stock units, each representing one share of Aura Biosciences Common Stock. These RSUs vest in three substantially equal annual installments starting July 15, 2027, provided he remains in service on each vesting date.
What are the terms of Jeremy Bender’s Aura Biosciences (AURA) stock options?
He received 60,000 stock options with an exercise price of $7.03 per share. The options vest in three substantially equal annual installments beginning July 7, 2027, and expire on July 7, 2036, assuming continued service.
Are Jeremy Bender’s Aura Biosciences (AURA) awards immediately vested or subject to conditions?
Both awards are subject to vesting conditions. The 30,000 RSUs and 60,000 stock options each vest in three substantially equal annual installments starting in 2027, contingent on Jeremy Bender’s continued service through each vesting date.
What are Jeremy Bender’s Aura Biosciences (AURA) holdings after these transactions?
Following the reported awards, Jeremy Bender directly holds 30,000 shares of Aura Biosciences Common Stock and 60,000 stock options, according to the Form 4 figures provided for post-transaction ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
